Taysha Gene Therapiesinc Stock Today
| TSHA Stock | USD 2.53 0.07 2.85% |
Performance10 of 100
| Odds Of DistressLess than 47
|
Taysha Gene is trading at 2.53 as of the 23rd of April 2024, a 2.85% increase since the beginning of the trading day. The stock's open price was 2.46. Taysha Gene has 47 percent odds of going through some form of financial distress in the next two years but had a very ok returns during the last 90 days. Equity ratings for Taysha Gene TherapiesInc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of May 2022 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 24th of September 2020 | Category Healthcare | Classification Health Care |
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company was incorporated in 2019 and is based in Dallas, Texas. The company has 187.02 M outstanding shares of which 16.99 M shares are at this time shorted by private and institutional investors with about 3.89 trading days to cover. More on Taysha Gene TherapiesInc
Moving together with Taysha Stock
| 0.89 | OPT | Opthea | PairCorr |
| 0.71 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
Moving against Taysha Stock
| 0.55 | PCRX | Pacira Pharmaceuticals Financial Report 1st of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Taysha Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Taysha Gene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Taysha Gene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Chairman | Sean Nolan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Taysha Gene report their recommendations after researching Taysha Gene's financial statements, talking to executives and customers, or listening in on Taysha Gene's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Taysha Gene TherapiesInc. The Taysha consensus assessment is calculated by taking the average forecast from all of the analysts covering Taysha Gene. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Taysha Gene's historical financial statements, Taysha Gene TherapiesInc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Taysha Gene TherapiesInc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taysha Gene's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Taysha Gene's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Taysha Gene's financial leverage. It provides some insight into what part of Taysha Gene's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taysha Gene TherapiesInc (TSHA) is traded on NASDAQ Exchange in USA. It is located in 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 and employs 52 people. Taysha Gene is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 460.06 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Taysha Gene's market, we take the total number of its shares issued and multiply it by Taysha Gene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Taysha Gene TherapiesInc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 187.02 M outstanding shares of which 16.99 M shares are at this time shorted by private and institutional investors with about 3.89 trading days to cover.
Taysha Gene TherapiesInc currently holds about 66.24 M in cash with (73.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.61.
Check Taysha Gene Probability Of Bankruptcy
Ownership AllocationTaysha Gene TherapiesInc shows a total of 187.02 Million outstanding shares. Over half of Taysha Gene's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Taysha Gene TherapiesInc. Please watch out for any change in the institutional holdings of Taysha Gene as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Taysha Ownership Details
Taysha Stock Price Odds Analysis
What are Taysha Gene's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Taysha Gene jumping above the current price in 90 days from now is about 35.07%. The Taysha Gene TherapiesInc probability density function shows the probability of Taysha Gene stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 3.5893. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Taysha Gene will likely underperform. Additionally, taysha Gene TherapiesInc has an alpha of 0.8113, implying that it can generate a 0.81 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Taysha Gene to move above the current price in 90 days from now is about 35.07 (This Taysha Gene TherapiesInc probability density function shows the probability of Taysha Stock to fall within a particular range of prices over 90 days) .
Taysha Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Taysha Gene that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Taysha Gene's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Taysha Gene's value.| Instituion | Recorded On | Shares | |
| Millennium Management Llc | 2023-12-31 | 3.4 M | |
| Tcg Crossover Management, Llc | 2023-12-31 | 2.9 M | |
| Octagon Capital Advisors Lp | 2023-09-30 | 2.8 M | |
| Blackrock Inc | 2023-12-31 | 2.7 M | |
| Polar Capital Holdings Plc | 2023-12-31 | 2.5 M | |
| Ghost Tree Capital, Llc | 2023-12-31 | 2.1 M | |
| Susquehanna International Group, Llp | 2023-12-31 | 1.4 M | |
| T. Rowe Price Associates, Inc. | 2023-12-31 | 1.2 M | |
| Renaissance Technologies Corp | 2023-12-31 | 1.1 M | |
| Fmr Inc | 2023-12-31 | 22.4 M | |
| Ra Capital Management, Llc | 2023-12-31 | 18.5 M |
Taysha Gene Historical Income Statement
Taysha Gene TherapiesInc Income Statement is one of the three primary financial statements used for reporting Taysha's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Taysha Gene TherapiesInc revenue and expense. Taysha Gene Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Taysha Gene's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 95.2 M, whereas Depreciation And Amortization is forecasted to decline to about 1.3 M. View More FundamentalsTaysha Stock Against Markets
Picking the right benchmark for Taysha Gene stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Taysha Gene stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Taysha Gene is critical whether you are bullish or bearish towards Taysha Gene TherapiesInc at a given time. Please also check how Taysha Gene's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Taysha Gene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Taysha Gene Corporate Management
Elected by the shareholders, the Taysha Gene's board of directors comprises two types of representatives: Taysha Gene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taysha. The board's role is to monitor Taysha Gene's management team and ensure that shareholders' interests are well served. Taysha Gene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taysha Gene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Greg Gara | VP Manufacturing | Profile | |
| Tracy Porter | Chief Officer | Profile | |
| Jim Rouse | Chief Officer | Profile | |
| R II | President, Founder | Profile | |
| FFPM MSc | Chief RD | Profile | |
| Steven Gray | Chief Program | Profile |
How to buy Taysha Stock?
Before investing in Taysha Gene, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Taysha Gene. To buy Taysha Gene stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Taysha Gene. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Taysha Gene stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Taysha Gene TherapiesInc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Taysha Gene TherapiesInc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Taysha Gene TherapiesInc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Taysha Stock please use our How to Invest in Taysha Gene guide.
Already Invested in Taysha Gene TherapiesInc?
The danger of trading Taysha Gene TherapiesInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Taysha Gene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Taysha Gene. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Taysha Gene TherapiesInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Taysha Gene TherapiesInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taysha Gene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taysha Gene Therapiesinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taysha Gene Therapiesinc Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taysha Gene TherapiesInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Taysha Gene TherapiesInc information on this page should be used as a complementary analysis to other Taysha Gene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Taysha Stock analysis
When running Taysha Gene's price analysis, check to measure Taysha Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taysha Gene is operating at the current time. Most of Taysha Gene's value examination focuses on studying past and present price action to predict the probability of Taysha Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taysha Gene's price. Additionally, you may evaluate how the addition of Taysha Gene to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Taysha Gene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taysha Gene. If investors know Taysha will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taysha Gene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 0.133 | Quarterly Revenue Growth 0.44 | Return On Assets (0.30) | Return On Equity (2.94) |
The market value of Taysha Gene TherapiesInc is measured differently than its book value, which is the value of Taysha that is recorded on the company's balance sheet. Investors also form their own opinion of Taysha Gene's value that differs from its market value or its book value, called intrinsic value, which is Taysha Gene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taysha Gene's market value can be influenced by many factors that don't directly affect Taysha Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taysha Gene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taysha Gene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taysha Gene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.